Chemcrux Enterprises (BSE 540395)₹80.26+2.59%Specialty Chemicals
In the Sep 2026 quarter (consolidated), Chemcrux Enterprises reported sales of ₹23.89 Cr, up 34.3% from Sep 2025, and net profit of ₹0.56 Cr, up 180.0% year on year. For the year to Mar 2026, sales were ₹80.81 Cr and net profit ₹3.72 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.85 | 18.59 | 17.16 | 17.79 | 19.47 | 15.74 | 16.54 | 17.79 | 22.17 | 24.33 | 21.97 | 23.89 |
| Expenses | 17.49 | 15.98 | 15.11 | 15.45 | 16.79 | 13.67 | 14.92 | 16.03 | 18.65 | 20.16 | 19.31 | 21.05 |
| Operating Profit | 4.39 | 2.63 | 2.07 | 2.37 | 2.70 | 2.12 | 1.64 | 1.80 | 3.54 | 4.19 | 2.71 | 2.86 |
| OPM % | 20.0% | 14.1% | 12.0% | 13.3% | 13.8% | 13.4% | 9.9% | 10.1% | 16.0% | 17.2% | 12.3% | 11.9% |
| Other Income | 0.57 | 0.36 | 0.40 | 0.25 | 0.62 | 0.25 | 0.45 | 0.64 | 0.61 | 0.35 | 0.12 | 0.08 |
| Interest | 0.18 | 0.14 | 0.14 | 0.34 | 0.61 | 0.70 | 0.87 | 0.84 | 0.77 | 0.71 | 0.65 | 0.63 |
| Depreciation | 0.59 | 0.54 | 0.55 | 0.74 | 0.93 | 1.00 | 1.17 | 1.19 | 1.18 | 1.18 | 1.17 | 1.21 |
| Profit before tax | 4.20 | 2.30 | 1.77 | 1.57 | 1.79 | 0.68 | 0.04 | 0.40 | 2.19 | 2.68 | 1.00 | 1.11 |
| Tax % | 36.8% | 3.5% | 29.6% | 26.3% | 25.9% | 68.7% | −233.3% | 46.2% | 28.0% | 30.8% | 48.5% | 51.0% |
| Net Profit | 2.65 | 2.20 | 1.23 | 1.16 | 1.31 | 0.20 | 0.10 | 0.20 | 1.59 | 1.84 | 0.50 | 0.56 |
| EPS (Rs) | 1.79 | 1.48 | 0.83 | 0.77 | 0.88 | 0.13 | 0.05 | 0.13 | 1.06 | 1.24 | 0.33 | 0.36 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| Sales | 95.50 | 95.32 | 78.66 | 70.11 | 80.81 | 92.36 |
| Expenses | 74.81 | 73.92 | 65.33 | 61.04 | 69.71 | 79.17 |
| Operating Profit | 20.77 | 21.53 | 13.41 | 9.25 | 11.18 | 13.30 |
| OPM % | 21.8% | 22.6% | 17.0% | 13.2% | 13.8% | 14.4% |
| Other Income | 1.01 | 1.06 | 1.19 | 1.50 | 2.01 | 1.16 |
| Interest | 0.18 | 0.83 | 0.84 | 1.76 | 3.16 | 2.76 |
| Depreciation | 1.60 | 2.03 | 2.28 | 3.22 | 4.74 | 4.74 |
| Profit before tax | 20.01 | 19.71 | 11.45 | 5.77 | 5.30 | 6.98 |
| Tax % | 25.6% | 27.0% | 26.2% | 32.2% | 29.4% | — |
| Exceptional items | 0.18 | 0.30 | 0.12 | 0.38 | 1.44 | — |
| Net Profit | 14.87 | 14.35 | 8.43 | 3.90 | 3.72 | 4.49 |
| EPS (Rs) | 10.02 | 9.69 | 5.69 | 2.63 | 2.51 | 2.99 |
| Dividend payout % | 19.9% | 20.7% | 17.6% | 37.9% | 39.7% | — |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 14.86 | 14.86 | 14.85 | 14.86 | 14.86 |
| Reserves | 39.94 | 51.70 | 57.54 | 59.94 | 62.16 |
| Borrowings | 9.79 | 14.49 | 26.57 | 42.50 | 34.51 |
| Other Liabilities | 19.44 | 12.43 | 11.21 | 10.17 | 16.30 |
| Total Liabilities | 84.03 | 93.48 | 110 | 127 | 128 |
| Fixed Assets | 25.55 | 33.19 | 33.19 | 77.34 | 75.22 |
| CWIP | 0.00 | 0.32 | 21.07 | 1.60 | 4.09 |
| Investments | 7.09 | 16.81 | 19.86 | 19.87 | 15.94 |
| Other Assets | 51.39 | 43.16 | 36.05 | 28.66 | 32.58 |
| Inventories | 11.59 | 14.11 | 8.43 | 10.03 | 6.12 |
| Trade receivables | 18.92 | 13.46 | 15.34 | 11.80 | 18.94 |
| Cash & equivalents | 11.92 | 7.12 | 5.20 | 1.16 | 2.58 |
| Total Assets | 84.03 | 93.48 | 110 | 127 | 128 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | 9.14 | 14.76 | 16.28 | 7.57 | 13.80 |
| Cash from investing activity | −2.65 | −20.54 | −25.93 | −5.99 | −0.08 |
| Cash from financing activity | 3.97 | 0.97 | 7.65 | −5.67 | −12.38 |
| Net cash flow | 10.46 | −4.69 | −1.90 | −4.03 | 1.41 |
| Capex | 4.60 | 11.15 | 24.22 | 8.38 | 5.14 |
| Free cash flow | 4.60 | 3.72 | −6.86 | −0.65 | 8.75 |
| CFO / OP % | 68.9% | 86.0% | 142.0% | 98.0% | 136.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 71 | 51 | 70 | 60 | 85 |
| Inventory days | 93 | 126 | 101 | 136 | 70 |
| Days payable | 92 | 70 | 70 | 60 | 104 |
| Cash conversion cycle | 72 | 105 | 100 | 136 | 49 |
| Working capital days | 37 | 67 | 55 | 28 | 16 |
| ROCE % | — | 27.7% | 13.5% | 6.7% | 6.5% |
For the Sep 2026 quarter, Chemcrux Enterprises reported sales of ₹23.89 Cr, up 34.3% year on year and net profit of ₹0.56 Cr, up 180.0% year on year. The operating margin was 11.9%.
Chemcrux Enterprises' sales for the year to Mar 2026 were ₹80.81 Cr; over the last twelve months they were ₹92.36 Cr.
Net profit for the year to Mar 2026 was ₹3.72 Cr, and ₹4.49 Cr over the last twelve months. Earnings per share over the same trailing period were ₹2.99.
Chemcrux Enterprises reported borrowings of ₹34.51 Cr at Mar 2026, against cash and equivalents of ₹2.58 Cr.
Cash from operations was ₹13.80 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹8.75 Cr.